|
Dec 4
|
Catalyst Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive Promotions
|
|
Nov 8
|
Catalyst Pharmaceuticals Reports Strong Third Quarter 2023 Financial Results and Corporate Update
|
|
Nov 2
|
Catalyst Pharmaceuticals Receives Two New U.S. Patent Allowances For FIRDAPSE®
|
|
Nov 2
|
Amylyx Pharmaceuticals, Inc. (AMLX) Earnings Expected to Grow: What to Know Ahead of Q3 Release
|
|
Nov 1
|
Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth
|
|
Sep 27
|
If EPS Growth Is Important To You, Catalyst Pharmaceuticals (NASDAQ:CPRX) Presents An Opportunity
|
|
Sep 8
|
Why Is Catalyst (CPRX) Down 14% Since Last Earnings Report?
|
|
Sep 6
|
Unraveling the Future of Catalyst Pharmaceuticals Inc (CPRX): A Deep Dive into Key Metrics
|
|
Aug 11
|
Catalyst Pharmaceuticals Second Quarter 2023 Earnings: EPS: US$0.35 (vs US$0.21 in 2Q 2022)
|
|
Aug 9
|
Catalyst Pharmaceutical (CPRX) Beats Q2 Earnings and Revenue Estimates
|
|
Aug 9
|
Catalyst Pharmaceuticals Reports Strong Second Quarter 2023 Financial Results and Provides Corporate Update
|